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Abstract 
Background. DNA methylation patterns associated with habitual diet have not been well studied. 
Methods and results. Diet quality was characterized using a Mediterranean-style diet score (MDS) and the 
Alternative Healthy Eating Index score (AHEI). We conducted ethnicity-specific and trans-ethnic 
epigenome-wide association analyses for diet quality and leukocyte-derived DNA methylation at over 
400,000 cytosine-guanine dinucleotides (CpGs) in five population-based cohorts including 6,662 
European ancestry (EA), 2,702 African ancestry (AA), and 360 Hispanic ancestry (HA) participants. For 
diet-associated CpGs identified in epigenome-wide analyses, we conducted Mendelian randomization 
(MR) analysis to examine their relations to cardiovascular disease (CVD) risk factors and examined their 
longitudinal associations with all-cause mortality. We identified 30 CpGs associated with either MDS or 
AHEI, or both, in EA participants. Among these CpGs, 12 CpGs were significantly associated with all-
cause mortality (Bonferroni corrected p-value < 1.6×10-3). Hypermethylation of cg18181703 (SOCS3) 
was associated with higher scores of both MDS and AHEI and lower risk for all-cause mortality (p-value 
= 5.7×10-15). Ten additional diet-associated CpGs were nominally associated with all-cause mortality (p-
value < 0.05). MR analysis revealed eight putatively causal associations for six CpGs with four CVD risk 
factors (BMI, triglycerides, high-density lipoprotein cholesterol concentrations, and type 2 diabetes; 
Bonferroni corrected MR p-value < 4.5×10-4). For example, hypermethylation of cg11250194 (FADS2) 
was associated with lower triglyceride concentrations (MR p-value = 1.5×10-14).and hypermethylation of 
cg02079413 (SNORA54; NAP1L4) was associated with BMI (corrected MR p-value = 1×10-6). Ten 
additional CpGs were associated with either MDS or AHEI at a false discovery rate <0.05 in trans-ethnic 
meta-analysis. 
Conclusions. Habitual diet quality was associated with differential peripheral leukocyte DNA methylation 
levels of 30 CpGs, most of which were also associated with multiple health outcomes, in EA individuals. 
These findings demonstrate that integrative genomic analysis of dietary information may reveal molecular 
targets for disease prevention and treatment.   
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Introduction 
Epigenetic alterations are involved in the pathogenesis of many human diseases.1 DNA methylation, 
which commonly occurs at cytosine–guanine dinucleotide (CpG) sites, is a well-studied epigenetic 
modification that may affect gene expression and contribute to the development of chronic diseases, 
including cardiovascular disease.2-4  
 
Several lines of evidence suggest that diet may be actively involved in epigenetic regulation, which 
impacts diet-related disease risk.5-8 Tremblay et al. measured genome-wide DNA methylation profiles 
before and after a six-week supplementation of daily dose of 3 grams of omega-3 polyunsaturated fatty 
acids (n-3 FAs) in 36 participants with BMI between 25 to 40 kg/m2.9 They found that n-3 FAs 
supplementation caused differential DNA methylation of 308 CpGs, which could be linked to 16 
pathways related to cardiovascular disease (CVD) including inflammatory response and lipid metabolism.  
 
While previous studies provide useful evidence that diet plays an important role in regulating the human 
epigenome, studies of DNA methylation signatures for overall diet quality, however, are few in number 
and limited by small sample sizes. Diet quality is crucial for chronic diseases prevention.10-12 In cohort 
studies, diet quality is often assessed using a variety of diet scores, including the Mediterranean-style diet 
score (MDS) and the Alternative Healthy Eating Index (AHEI) score.13-18 These studies showed that a 
higher diet score was associated with lower disease burden. A thorough insight into the biological 
mechanisms underlying diet-disease associations is important for disease prevention and treatment. To fill 
this knowledge gap, we conducted an epigenome-wide association study of diet quality, assessed by MDS 
and AHEI, with peripheral blood-derived DNA methylation in cohorts with representation of individuals 
of European as well as non-European ancestries.  
 
Methods 
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The study design is presented in Figure 1. The datasets analyzed in the present study are available at the 
dbGAP repository phs000280.v5.p1 (ARIC), phs000007.v29.p10 (FHS), phs000741.v2.p1 (GOLDN), 
phs000209.v13.p3 (MESA), phs000853.v1.p1 (NAS), and phs000821.v1.p1 (LBC; phenotypic data). RS 
has a protocol for approving data requests (secretariat.epi@erasmusmc.nl). The informed consents given 
by KORA study participants do not cover data posting in public databases. However, data are available 
upon request from KORA Project Application Self-Service Tool (https://epi.helmholtz-muenchen.de/) 
Data requests can be submitted online and are subject to approval by the KORA Board. Methylation data 
of LBC have been submitted to the European Genome-phenome Archive under accession number 
EGAS00001000910. For ESTHER and InCHIANTI, the datasets used and/or analyzed during the current 
study are available from the corresponding author upon request. Data for WHI and CHS can be requested 
at https://www.whi.org/researchers/SitePages/Write%20a%20Paper.aspx and https://chs-
nhlbi.org/node/6222, respectively. The study protocol was approved by each participating institutions’ 
Institutional Review Board. All participants provided written informed consent. Full descriptions of study 
populations, phenotypic definitions, DNA methylation profiling, and statistical analyses are available in 
the Supplemental Material.  
 
Results 
Epigenome-wide association analysis in European Ancestry (EA) participants. We analyzed 403,087 
autosomal CpGs. For each diet quality score, either MDS or AHEI, we conduct two analyses, a two-step 
analysis (i.e., discovery and replication) and an one-step analysis (i.e., meta-analysis of all cohorts with 
internal validation). For MDS, the discovery analysis identified 13 CpGs at false discovery rate (FDR) < 
0.05 (corresponding p-value = 1.5×10-6; Supplemental Table 3; Supplemental Figure 1 [Manhattan plot] 
and Supplemental Figure 2 [Quantile-Quantile plot]). Of these CpGs, three replicated in the replication 
samples after Bonferroni correction (corresponding p-value < 0.004; Supplemental Table 3). The one-step 
analysis identified 12 CpGs associated with MDS at FDR < 0.05 (corresponding p-value = 1.2×10-6; 
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Supplemental Table 4; Supplemental Figure 3 [Manhattan plot] and Supplemental Figure 2 [Quantile-
Quantile plot]). Using models with adjustment for sex, age, and energy intake, the two analyses (two-step 
analysis and one-step analysis) identified 14 CpGs associated with MDS.  
 
For AHEI, in the two-step analysis, the discovery step identified 41 CpGs at FDR < 0.05 (corresponding 
p-value = 6×10-6; Supplemental Table 5; Supplemental Figure 1 [Manhattan plot] and Supplemental 
Figure 2 [Quantile-Quantile plot]). Two CpGs replicated after Bonferroni correction (corresponding p-
value < 0.001; Supplemental Table 5). The one-step analysis identified 24 CpGs at FDR < 0.05 
(corresponding p-value = 3.1×10-6; Supplemental Table 6; Supplemental Figure 3 [Manhattan plot] and 
Supplemental Figure 2 [Quantile-Quantile plot]). The combination of the two-step analysis and the one-
step identified 24 CpGs associated with AHEI using models adjusted for sex, age, and energy intake.  
 
To reduce potential confounding effects by other lifestyle factors, we additionally adjusted for smoking 
status, physical activity, and BMI. Among the 14 CpGs associated with MDS, ten CpGs remained 
significant (p-value < 0.05/14; Figure 2), while all 24 CpGs associated with AHEI remained significant 
(p-value < 0.05/24; Figure 2). Overall, after adjustment for multiple confounders, we identified 30 CpGs 
associated with either MDS or AHEI, or both (Table 1). Pairwise correlations of the 30 CpGs were low to 
moderate, absolute Pearson r ranging from 0 to 0.66 (Supplemental Table 7).  As shown in Supplemental 
Figure 4, regression coefficients in meta-analyses of all EA participants using MDS and AHEI were 
highly correlated, e.g., Pearson r was 0.97 for the regression coefficients of the top 500 CpGs in MDS 
versus AHEI. We therefore combined the CpGs identified using the two diet scores in the subsequent 
analyses.  
 
Functional and regulatory annotation of diet-associated CpGs. Relative to the whole set of CpGs 
analyzed, the 30 diet-associated CpGs were enriched in gene body regions (p-value = 9.3×10-4). The mean 
 
R9 
 
 
whole blood-derived DNA methylation levels of the 30 CpGs were moderately associated with those 
measured in muscle, omentum, and spleen (Supplemental Figure 5), with Spearman ranked r = 0.56 
(n=6), 0.60 (n=6), and 0.62 (n=3); p-value = 1.5×10-3, 6.1×10-4, and 3.5×10-4, respectively.19  
 
Among the 30 CpGs, 26 CpGs were annotated to 27 protein-coding genes (Supplemental Table 8). Based 
on the GTEx expression dataset,20 the annotated genes were differentially expressed in several tissues 
(Supplemental Figure 6 and Supplemental Table 9), e.g., differential expression was reported for 17 genes 
in muscle and 12 genes in small intestine (Bonferroni corrected p-value = 0.03 and 0.04, respectively). 
Gene set analyses did not reveal significant enrichment of pathways. Several genes, however, have 
important biological functions relevant to diet-associated diseases, e.g., SORBS1 (annotated to 
cg03190891) and FADS2 (annotated to cg11250194) play crucial roles in insulin signaling and fatty acids 
metabolism, respectively.  
 
GWAS analysis. We identified 4,925 cis-meQTL variants for 23 of the 30 CpGs in the FHS 
(Supplemental Material). We found that 68 cis-meQTL variants for ten CpGs exactly matched a GWAS 
reported single nucleotide polymorphism (SNP) in the NHGRI-EBI GWAS Catalog21 (p-value < 5×10-8; 
Supplemental Table 10). For example, rs174550 for cg11250194 (FADS2) was associated with plasma 
omega-6 polyunsaturated fatty acid concentrations.22 Overall, these ten CpGs were linked to 35 unique 
traits, of which many are also diet-associated, such as lipid levels and chronic kidney disease.23,24  
 
Associations of diet-associated CpGs with CVD risk factors. In the EWAS catalog (Supplemental Table 
11), we found that 26 (of 30) CpGs have been reported to be associated with one or more CVD risk 
factors, e.g., hypermethylation of cg18181703 (SOCS3) was associated with lower BMI and lower risk of 
type 2 diabetes. 25-27 We conducted bidirectional Mendelian Randomization (MR) analysis to examine the 
potential causal relations between diet-associated CpGs and CVD risk factors, i.e., CpG  CVD trait and 
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CVD trait  CpG. The MR analysis in direction of CpG to CVD trait was performed for 22 (of 30) CpGs 
that had cis-meQTL variants and summary results from the selected GWAS. We found significant 
putatively causal association for eight CpG-trait pairs after Bonferroni correction for 22 CpGs and five 
traits (corresponding MR p-value < 4.5×10-4) and nominally significant putatively causal association for 
14 CpG-trait pairs (MR p-value < 0.05; Supplemental Table 12). For example, as shown in Figure 3, 
hypermethylation of cg11250194 (FADS2) was associated with lower triglyceride concentrations (MR p-
value = 1.5×10-14) and hypermethylation of cg02079413 (SNORA54; NAP1L4) was associated with higher 
BMI (MR p-value = 1×10-6). We also observed unexpected associations in the MR analysis. For example, 
hypermethylation of cg26470501 (BCL3) was positively associated with BMI (MR p-value = 6.5×10-5; 
Supplemental Table 12; Figure 3), which was not consistent with the positive association that we 
observed between diet and this CpG and the inverse association between this CpG and BMI.25,28 In the 
opposite direction, MR analyses linking CVD traits to CpG, revealed no significant putative causal 
association after correction for multiple testing (p-value < 0.002; 0.05/30 diet-associated CpGs; 
Supplemental Table 13). Nevertheless, we observed two nominally significant associations: higher BMI 
was associated with hypomethylation of cg18181703 (p-value = 0.04) and higher waist-to-hip ratio 
adjusted for BMI (WHRadjBMI) was associated with hypomethylation of cg25953130 (p-value = 0.02). 
 
Relations of diet-associated CpGs with mortality. Of the 30 diet score-associated CpGs, the relations of 
27 CpGs with all-cause mortality were examined in ten EA cohorts (N up to 10,083). Three CpGs were 
excluded because of missing data. After adjusting for multiple covariates (Figure 4), we found that 12 
CpGs were significantly associated with all-cause mortality following Bonferroni correction 
(corresponding p-value < 1.6×10-3); ten additional CpGs were nominally associated with all-cause 
mortality (p-value < 0.05). The direction of the associations between CpGs and mortality was concordant 
with that for the diet-CpG associations, e.g., hypermethylation of cg18181703 (SOCS3), which was 
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associated with higher scores of both AHEI and MDS, was associated with lower all-cause mortality (p-
value = 5.7×10-15).  
 
Multiethnic analysis. Although we observed largely consistent directions of effect in AA and HA 
participants for the 30 CpGs identified in EA participants, none of these CpGs was significant after 
Bonferroni correction (Supplemental Table 14). The transethnic meta-analysis identified 21 CpGs at FDR 
< 0.05 including 13 CpGs for AHEI with a corresponding p-value of 1.1×10-6 and 10 CpGs for MDS with 
a corresponding p-value of 7×10-7 (Supplemental Table 15). Of the 21 CpGs, ten CpGs were not among 
the 30 CpGs identified in EA participants and the correlations of the ten CpGs with the 30 CpGs were low 
to moderate, |r| ranging from 0 to 0.49 (Supplemental Table 17). The annotated genes for these ten CpGs 
(Supplemental Table 18) showed enrichment of lipid metabolism-related pathways (Supplemental Table 
18). Nine of the ten CpGs were associated with nine unique traits in the EWAS catalog including serum 
triglyceride and HDL concentrations 29 (Supplemental Table 19). 
 
Discussion 
In participants of EA ancestry, we identified 30 CpGs whose methylation in whole blood was associated 
with diet scores assessed, either MDS or AHEI, or both. Aligning cis-meQTL variants for these CpGs 
with GWAS catalog reported variants revealed that diet-associated differential DNA methylation can be 
linked to a series of metabolic and inflammatory disorders. Importantly, we also observed associations 
between these CpGs and all-cause mortality, which may reflect the importance of diet-induced epigenetic 
changes on health outcomes. Our study provides novel evidence that integrative genomic analysis of 
dietary information may be useful to highlight molecular targets for disease prevention and treatment. 
 
Accumulating evidence has shown that epigenetic profiles may be regulated by dietary factors.6 A recent 
study found that women who had better adherence to the Mediterranean diet had greater DNA 
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methylation levels at long interspersed nucleotide elements 1 (LINE-1), a surrogate marker of global 
genomic DNA methylation.8 In a small subgroup (n=36) of the Prevención con Dieta Mediterránea 
(PREDIMED) study, genome-wide methylation levels in peripheral blood derived DNA were assessed at 
baseline and again five years later.7 This study revealed that adherence to the Mediterranean diet may 
impact DNA methylation levels of several inflammation-related genes. None of the CpGs identified in 
this PREDIMED report, however, showed statistically significant differential DNA methylation in the 
meta-analysis in the present study. 
 
Higher MDS and AHEI scores have been reported to be associated with lower body weight.17,18 Our 
observation that diet scores were positively associated with DNA methylation levels of cg18181703 
(SOCS3) is therefore consistent with the inverse association of cg18181703 and BMI identified in 
multiple studies.25,28,30 Overall, by integrating association analysis and MR analysis, our data indicate that 
diet quality may affect BMI, alter DNA methylation of cg18181703, and impact long-term health. The 
association between cg18181703 and all-cause mortality also was consistent with observations in a small-
scale epigenome-wide study.31 SOCS3 is a well characterized gene involved in immune system regulation, 
which suggests that the association of diet scores and cg18181703 may be relevant to inflammation and 
may partly explain the association of cg18181703 with all-cause mortality.  
 
Several diet score-associated CpGs, such as cg19693031 (TXNIP) and cg02716826 (SUGT1P1; AQP3), 
have been reported to be associated with CVD risk factors.26,27 TXNIP, thioredoxin-interacting protein, is 
a key regulator of energy metabolism and a therapeutic candidate for type 2 diabetes.32 AQP3, aquaporin 
3, is a member of water channel proteins that are associated with a number of diseases such as 
hypertension and congestive heart failure.33 Our MR analyses also support a causal link between 
methylation levels of diet-associated CpGs and CVD risk factors, e.g., hypermethylation of cg11250194 
(FADS2) was associated with lower triglyceride concentrations. FADS2 is a key member of the fatty acid 
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desaturase (FADS) family.34 This observation is consistent with the role of diet in the regulation of 
enzyme activity relevant to fatty acid desaturation.35 Therefore, the present study provides key evidence 
that diet may interact with the human genome via epigenetic mechanisms to impact health outcomes.  
 
A major strength of the present study is its large sample size, which includes data from five US and 
European population-based cohorts, and the use of two common and well-studied diet scores. Several 
limitations warrant discussion. The diet scores were based on different versions of FFQs, which are prone 
to measurement errors due to self-reported diet data. In addition, although the associations remained 
significant for the majority of CpGs after adjustment for lifestyle factors, we cannot rule out the 
possibility of residual confounding. Although we showed a moderate correlation between peripheral 
blood-derived DNA methylation profiles and those from other tissues, we lacked data to analyze tissue-
specific diet-associated DNA methylation changes which may be more directly related to the 
development of chronic diseases. Our study may lack power to detect diet-associated DNA methylation 
markers in AA and HA participants due to the smaller sample sizes (n=2,702 for AA and n=360 for HA) 
relative to EA participants (n=6,662). 
 
In conclusion, the present study demonstrates that diet quality is associated with differential DNA 
methylation levels of 30 CpGs in leukocyte-derived DNA among EA participants. Our findings 
demonstrate that integration of dietary information and genomic data may reveal useful insights into the 
molecular effects at the intersection of diet, risk factors, and chronic diseases. Future studies with larger 
sample sizes, deeper coverage of DNA methylation, and more precise dietary measurement are needed to 
validate our findings and to investigate diet-associated DNA methylation patterns in larger ethnically 
diverse samples.  
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Table 1. Diet scores-associated CpGs in European Ancestry (EA) meta-analysis 
CpG CHR Position Gene Diet 
Meta-analysis in all EA participants 
Beta SE P Direction I-squared 
cg04885881 1 11123118 
 
MDS 0.004 0.001 3.2E-07 +, +, +, +, + 0.12 
cg24735226 1 65096537 CACHD1 AHEI -0.004 0.001 1.6E-06 -, -, -, -, - 0 
cg07805029 1 92953256 GFI1 AHEI 0.003 0.001 3.1E-06 +, +, +, +, + 0 
cg19693031 1 145441552 TXNIP MDS 0.003 0.001 3.1E-07 +, +, +, +, + 0.14 
cg24694018 1 145457621 POLR3GL AHEI 0.002 0.0003 8.3E-07 +, +, +, +, + 0 
cg01940273 2 233284934 
 
MDS 0.005 0.001 1.6E-12 +, +, +, +, + 0 
cg20842915 7 39665132 RALA AHEI 0.003 0.001 8.1E-08 +, +, +, +, + 0 
cg02508743 8 56903623 LYN AHEI -0.002 0.001 2.5E-06 -, -, -, -, - 0 
cg27039118 8 116575902 TRPS1 AHEI 0.004 0.001 1.2E-06 +, +, +, +, + 0 
cg02716826 9 33447032 SUGT1P1;AQP3 MDS 0.002 0.0005 5.6E-07 +, +, +, +, + 0 
cg25953130 10 63753550 ARID5B AHEI 0.004 0.001 1.2E-08 +, +, +, +, + 0 
cg03190891 10 97201172 SORBS1 AHEI -0.003 0.0005 9.0E-08 -, -, -, -, - 0 
cg02079413 11 2986505 SNORA54;NAP1L4 MDS -0.002 0.0004 3.1E-07 -, -, -, -, - 0.14 
cg11250194 11 61601937 FADS2 AHEI 0.003 0.001 1.5E-06 +, +, +, +, + 0 
cg11468085 11 67435577 ALDH3B2 AHEI -0.002 0.0005 1.4E-06 -, -, -, -, - 0.06 
cg25909064 11 120082805 OAF AHEI 0.002 0.0004 8.0E-07 +, +, +, +, + 0 
cg03646329 13 48987165 LPAR6;RB1 AHEI 0.003 0.001 1.5E-06 +, +, +, +, + 0 
    
MDS 0.004 0.001 1.1E-06 +, +, +, +, + 0 
cg16969872 13 79968324 RBM26 AHEI 0.003 0.001 3.0E-09 +, +, +, +, + 0 
    
MDS 0.003 0.001 1.2E-06 +, +, +, +, + 0.25 
cg09940677 14 103415458 CDC42BPB AHEI -0.001 0.0003 2.9E-06 -, -, -, -, - 0 
cg13074055 14 106329206 
 
AHEI 0.005 0.001 1.3E-06 +, +, +, +, + 0 
cg27118035 16 31891978 ZNF267 AHEI -0.003 0.0005 4.9E-09 -, -, -, -, - 0 
cg08732950 16 89023389 CBFA2T3 MDS -0.003 0.0005 2.8E-08 -, -, -, -, - 0 
cg02097604 17 17750910 TOM1L2 AHEI 0.002 0.0003 6.6E-09 +, +, +, +, + 0 
    
MDS 0.002 0.0003 3.6E-08 +, +, +, +, + 0 
cg16936953 17 57915665 VMP1 AHEI 0.004 0.001 1.5E-08 +, +, +, +, + 0 
cg18181703 17 76354621 SOCS3 AHEI 0.004 0.001 2.0E-12 +, +, +, +, + 0 
    
MDS 0.004 0.001 3.5E-10 +, +, +, +, + 0 
cg19202384 17 79894511 PYCR1 AHEI 0.002 0.0004 9.9E-07 +, +, +, +, + 0.04 
cg01294327 19 2291373 LINGO3 AHEI 0.005 0.001 1.4E-06 +, +, +, +, + 0 
cg26470501 19 45252955 BCL3 AHEI 0.002 0.0004 2.4E-06 +, +, +, +, + 0.03 
cg08884571 19 45901453 PPP1R13L AHEI -0.004 0.001 4.6E-07 -, -, -, -, - 0 
cg05232694 20 48809539 
 
AHEI 0.004 0.001 3.1E-08 +, +, +, +, + 0 
Genome build 37. Regression coefficients are DNA methylation change for per standard deviation change in diet 
scores from analyses using sex, age, and energy intake adjusted models. Direction order (from left to right): FHS, 
ARIC, GOLDN, MESA, and RS. AHEI: Alternative Healthy Eating Index. MDS: Mediterranean-style diet score. 
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Figure 1. Study design flow chart. AA: African ancestry. EA: European ancestry. HA: Hispanic ancestry. CpGs: cytosine-guanine dinucleotides (DNA 
methylation sites). AHEI: Alternative Healthy Eating Index. MDS: Mediterranean-style diet score. FDR: false discovery rate. GWAS: genome-wide association 
study. cis-meQTLs: cis methylation quantitative loci. EWAS: epigenome-wide association study. GEO: Gene Expression Omnibus. GTEx: Genotype-Tissue 
Expression database. Discovery cohort: Framingham Heart Study (FHS). Replication cohorts: Atherosclerosis Risk in Communities (ARIC) Study, Genetics of 
Lipid Lowering Drugs and Diet Network (GOLDN), Multi-Ethnic Study of Atherosclerosis (MESA), and Rotterdam Study (RS). Cohorts for all-cause mortality 
includes: ARIC, FHS, ESTHER study, InChianti Study, Lothian Birth Cohort (LBC) Study 1921 and 1936, Cardiovascular Health Study (CHS), KORA F4 
Study, Normative Aging Study (NAS), and Women's Health Initiative (WHI).  
Two-step analysis One-step analysis 
Discovery 
3,266 EA participants  
400K autosomal CpGs 
2 Diet scores (AHEI & MDS) 
FDR<0.05 
Replication 
 3,396 EA participants  
Bonferroni corrected p-values 
5 Replicated CpGs 
3 CpGs by MDS & 2 CpGs by AHEI 
Meta-analysis in EA 
(Discovery + Replication) 
N=6,662 
FDR<0.05 
Internal Replication 
P-value < 0.05 in both 
Discovery and Replication 
with identical direction 
32 CpGs 
12 CpGs by MDS 
24 CpGs by AHEI 
• GWAS catalog (cis-meQTLs) & EWAS catalog lookups  
• Enrichment analysis (e.g., KEGG pathway & GO analysis) 
• Comparison of DNA methylation levels in multiple tissues (GEO: GSE48472)  
• Genes expression in multiple tissues in GTEx 
• Association between diet-associated CpGs and mortality and cardiovascular risk factors 
• Mendelian Randomization analysis to test potential causal relation of diet-associated 
CpGs with cardiovascular risk factors  
34 CpGs (14 by MDS and 24 by AHEI) 
Multiethnic Analysis 
N=9,724 (EA, AA, & HA) 
EA: N=6,662 (Discovery + Replication samples) 
AA: N=2,702 
HA: N= 360 
21 significant CpGs  
(FDR < 0.05) 
11 overlapping CpGs 
10 unique transethnic 
significant CpGs 
43 Discovered CpGs 
13 CpGs by MDS & 41 CpGs by AHEI 
30 Diet-associated CpGs (10 by MDS and 24 by AHEI) 
Adjustment for lifestyle (smoking status and physical activity level) and BMI 
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Figure 2. Effect of additional adjustment for lifestyle factors (smoking and physical activity) and BMI in European ancestry participants. A and B are 14 CpGs 
identified using the Mediterranean-style diet score (MDS). C and D are 24 CpGs identified using the Alternative Healthy Eating Index (AHEI). CpGs highlighted 
in red-colored rectangle are those identified in the two-step analysis alone and CpGs highlighted in green-colored rectangle are those identified in both one-step 
and two-step analyses. Orange colored dash line represents -log10 of 0.05 and green colored dash line represents -log10 of Bonferroni corrected p-value 
threshold, i.e., 0.05/14 for MDS and 0.05/24 for AHEI. Four CpGs (cg05575921, cg06126421, cg12075928, and cg25189904) in MDS analysis became non-
significant after Bonferroni correction in models with adjustment for lifestyle factors and BMI, whereas all 24 CpGs in AHEI analysis remained significant. 
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Figure 3. Mendelian Randomization (MR) analyses for associations between cg11250194 (FADS2) and triglycerides (TG), between cg02079413 (SNORA54; 
NAP1L4) and BMI, and between cg26470501 (BCL3) and BMI. IVW: inverse variance weighted. Symbols and bars represent effects size and standard errors of 
instruments variables (cis-meQTL variants) used in MR analysis. Solid line is for MR-IVW analysis and dashed line is for MR-Egger analysis. No horizontal 
pleiotropy effect was detected for all MR analyses. 
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Figure 4. Meta-analysis of association between 30 diet-associated CpGs and all-cause mortality in 10 cohorts of 
European ancestry participants (n≈10,000). A positive sign for diet indicates that a higher dietary scores (MDS or 
AHEI, or both) were associated with DNA hypermethylation, whereas, a hazard ratio of over 1.0 indicates that DNA 
hypermethylation was associated with increased all-cause mortality. Models were adjusted for baseline covariates 
including sex, age, smoking status, physical activity level, alcohol intake, BMI, and prevalence disease status of 
hypertension, type 2 diabetes, cardiovascular disease, and cancer. Estimated leukocyte counts, technical variables, 
and kinship (for related study samples) were also considered. Hazard ratios and 95% confidence interval were 
estimated using Cox proportional hazard models and meta-analyzed using random effect models. X-axis is in 
logarithmic scale. 
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